A methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine.
Stars
This entity has been manually annotated by the ChEBI Team.
lenvatinib mesylate
(CHEBI:85995)
has part
lenvatinib(1+)
(CHEBI:85998)
lenvatinib mesylate
(CHEBI:85995)
has role
antineoplastic agent
(CHEBI:35610)
lenvatinib mesylate
(CHEBI:85995)
has role
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
(CHEBI:62434)
lenvatinib mesylate
(CHEBI:85995)
has role
fibroblast growth factor receptor antagonist
(CHEBI:63457)
lenvatinib mesylate
(CHEBI:85995)
has role
orphan drug
(CHEBI:71031)
lenvatinib mesylate
(CHEBI:85995)
has role
vascular endothelial growth factor receptor antagonist
(CHEBI:65207)
lenvatinib mesylate
(CHEBI:85995)
is a
methanesulfonate salt
(CHEBI:38037)